Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Gill

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Cancer Medicine|September 24, 2022
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundationJonathan L Metts, Matteo Trucco, Daniel A Weiser, et al.
Pediatric Blood & Cancer|April 23, 2014
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology studySarah Gorlick, Donald A Barkauskas, Mark Krailo, et al.
Nuclear Medicine and Biology|October 17, 2016
Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)David S Geller, Jonathan Morris, Ekaterina Revskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2David S Geller, Michael Y Singh, Wendong Zhang, et al.
Genes & Cancer|April 25, 2017
Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma modelYi Yang, Rui Yang, Michael Roth, et al.
Research Square|August 23, 2023
In-person and virtual adaptation of an interprofessional palliative care communications skills training course for pediatric oncology cliniciansKaren M Moody, Clark Andersen, Julie Bradley, et al.
Cancer Medicine|December 31, 2015
Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignanciesDamon R Reed, Leo Mascarenhas, Kathleen Manning, et al.
Journal of Genetic Counseling|January 16, 2024
Families' experiences accessing care after genomic sequencing in the pediatric cancer context: "It's just been a big juggle"Blake Vuocolo, Amanda M Gutierrez, Jill O Robinson, et al.
Scientific Reports|August 27, 2024
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft modelsChia-Chin Wu, Licai Huang, Zhongting Zhang, et al.
BJU International|November 30, 2023
Health-related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first yearZoe Rogers, Adam Glaser, James W F Catto, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Cancer Medicine|September 24, 2022
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundationJonathan L Metts, Matteo Trucco, Daniel A Weiser, et al.
Pediatric Blood & Cancer|April 23, 2014
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology studySarah Gorlick, Donald A Barkauskas, Mark Krailo, et al.
Nuclear Medicine and Biology|October 17, 2016
Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)David S Geller, Jonathan Morris, Ekaterina Revskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
Development of a Model System to Evaluate Local Recurrence in Osteosarcoma and Assessment of the Effects of Bone Morphogenetic Protein-2David S Geller, Michael Y Singh, Wendong Zhang, et al.
Genes & Cancer|April 25, 2017
Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma modelYi Yang, Rui Yang, Michael Roth, et al.
Research Square|August 23, 2023
In-person and virtual adaptation of an interprofessional palliative care communications skills training course for pediatric oncology cliniciansKaren M Moody, Clark Andersen, Julie Bradley, et al.
Cancer Medicine|December 31, 2015
Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignanciesDamon R Reed, Leo Mascarenhas, Kathleen Manning, et al.
Journal of Genetic Counseling|January 16, 2024
Families' experiences accessing care after genomic sequencing in the pediatric cancer context: "It's just been a big juggle"Blake Vuocolo, Amanda M Gutierrez, Jill O Robinson, et al.
Scientific Reports|August 27, 2024
Whole genome and reverse protein phase array landscapes of patient derived osteosarcoma xenograft modelsChia-Chin Wu, Licai Huang, Zhongting Zhang, et al.
BJU International|November 30, 2023
Health-related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first yearZoe Rogers, Adam Glaser, James W F Catto, et al.
Pageof 7